Ms. Magazine
So...Are You Two Together?
You share a home and a life with your best girlfriend. What do you call that?

- What?
- Just the Facts
- Word: No
- Women to Watch

Uppity Woman
A puppet maker on a mission.
- Unconscionable Care
- Cardinal Sins
- Healthnotes
Life and Death in Iraq
Our reporter goes inside Iraq to learn firsthand what sanctions have done to the lives of women.
Did the Women's Museum Wimp Out?
While many have raved about the new Women's Museum in Dalls, others say it soft-pedals the details of the struggle for women's rights.
Portfolio: Eyes of the Beholder
African American women photographers turn the "gaze" inside out.
Breaking from Tradition: Two Great Singers from Mali.
My Dreams, My Works, Must Wait Till After Hell by Gwendolyn Brooks

Ms News

Editor's Page: Mothering Our Mothers

-A History of the Wife, by Marilyn Yalom
-Freedom's Daughters, by Lynne Olson
-Kamikaze Lust, by Lauren Sanders
-Manmade Breast Cancers, by Zillah Eisenstein
-Smell, by Radhika Jha

-First Person: Slut, Interrupted
-Columns: Daisy Hernandez, Patricia Smith and Gloria Steinem
Call for Woman of the Year
Tell us who you think should be recognized in this special issue.

By Sheri M. Whitley

Each year, nearly twice as many U.S. women die from heart disease as from all cancers combined. And though more men than women suffer from heart disease, the mortality rate is higher among women. One reason may be that women have been left out of most clinical trials, so less is known about how the disease affects us. But the FDA is now encouraging women to take part in trials and the Society for Women's Health Research, a Washington, D.C., nonprofit, is offering an information kit on existing trials and a resource list if you want to participate. Call (877) 332-2636 or visit

In a victory for privacy and women's rights, the Supreme Court ruled in March that hospitals cannot perform drug tests on pregnant women without their consent. A South Carolina hospital began employing the practice in 1989 in an effort, it said, to protect the unborn children of women suspected of using drugs. But since some of the women who tested positive were arrested from their hospital beds immediately after giving birth, the Supreme Court ruled that the primary focus of the policy was to collect evidence for prosecution, a violation of patients' rights to protection from unlawful searches. Dissenting Justices Rehnquist, Scalia, and Thomas, ever eager to promote their conservative views on reproductive issues, wrote that the majority's ruling proved "once again that no good deed goes unpunished."

Among women with breast cancer, those without health insurance are 49% more likely to die than those with insurance. The Breast and Cervical Cancer Prevention and Treatment Act, signed into law last October by President Clinton after lobbying by grassroots activists, will make it easier for these women to receive treatment. The legislation gives states the option to provide medical assistance to women diagnosed with breast and cervical cancer through a federal screening program. Previously, the program diagnosed the cancer, but left women without medical insurance in the lurch.

In an intriguing new series of ads for a menopausal supplement dubbed Remifemin, pharmaceutical giant GlaxoSmithKline asks, "Are you a Remifeminist?" Why would a company rely on the word "feminist" to sell a product — especially when the media insists that feminism is a negative term? Research at Glaxo showed that most perimenopausal and menopausal women had positive associations with the word, so it made sense to use it when selling a drug that relieves menopausal symptoms. Michele Klingensmith, a senior marketing exec for Glaxo, says, "Menopause is a time when many women feel isolated and are experiencing lots of change in their lives, and the word 'feminism' is associated with bonding and connecting with other women." We couldn't have said it better.